871 results on '"Aust, Daniela"'
Search Results
2. Multinational proficiency tests for EGFR exon 20 insertions reveal that the assay design matters
3. Identification of novel snoRNA-based biomarkers for clear cell renal cell carcinoma from urine-derived extracellular vesicles
4. Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based threshold
5. Correlation of microscopic tumor extension with tumor microenvironment in esophageal cancer patients
6. Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy
7. Benchmarking whole exome sequencing in the German network for personalized medicine
8. Colitis-ulcerosa-assoziierte Karzinogenese: Ein Update
9. An interpretable automated detection system for FISH-based HER2 oncogene amplification testing in histo-pathological routine images of breast and gastric cancer diagnostics
10. Label-free multiphoton microscopy enables histopathological assessment of colorectal liver metastases and supports automated classification of neoplastic tissue
11. Exceptional Response of BRAFV600E-Mutated Acinar Cell CUP to BRAF/MEK Inhibition
12. Identification of Epigenetically Regulated Genes Distinguishing Intracranial from Extracranial Melanoma Metastases
13. The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice
14. Immunohistochemical analyses of paraffin-embedded sections after primary surgery or trimodality treatment in esophageal carcinoma
15. Exceptional Response of BRAF V600E -Mutated Acinar Cell CUP to BRAF/MEK Inhibition.
16. Microbiota-dependent activation of the myeloid calcineurin-NFAT pathway inhibits B7H3- and B7H4-dependent anti-tumor immunity in colorectal cancer
17. Macroscopic, histologic, and clinical assessment of acute graft-versus-host disease of the upper gastrointestinal tract within 6 weeks after allogeneic hematopoietic cell transplantation
18. Molekularpathologische Diagnostik
19. Status quo of ALK testing in lung cancer: results of an EQA scheme based on in-situ hybridization, immunohistochemistry, and RNA/DNA sequencing
20. Impact of resection margin status on survival in advanced N stage pancreatic cancer – a multi-institutional analysis
21. Multi-omics profiling of living human pancreatic islet donors reveals heterogeneous beta cell trajectories towards type 2 diabetes
22. Exploring evolutionary trajectories in ovarian cancer patients by longitudinal analysis of ctDNA.
23. The effect of the triazene compound CT913 on ovarian cancer cells in vitro and its synergistic interaction with the PARP-inhibitor olaparib
24. Post-transcriptional regulation of insulin mRNA storage by G3BP1/2+ condensates in beta cells
25. Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis
26. Nicht kleinzelliges Lungenkarzinom – Vorreiter der personalisierten Onkologie
27. Distribution of histopathological features along the colon in microscopic colitis
28. Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis
29. Gamma-delta T cells stimulate IL-6 production by pancreatic stellate cells in pancreatic ductal adenocarcinoma
30. Detection of pancreatic ductal adenocarcinoma with galectin-9 serum levels
31. Sporadic multiple meningiomas harbor distinct driver mutations
32. Mouse Models of Human Gastric Cancer Subtypes With Stomach-Specific CreERT2-Mediated Pathway Alterations
33. Metabolically phenotyped pancreatectomized patients as living donors for the study of islets in health and diabetes
34. Repeat FMISO-PET imaging weakly correlates with hypoxia-associated gene expressions for locally advanced HNSCC treated by primary radiochemotherapy
35. The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma
36. Utility of fiducial markers for target positioning in proton radiotherapy of oesophageal carcinoma
37. Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma
38. Zielgerichtete Systemtherapie beim operablen Lungenkarzinom.
39. Community-driven development of a modified progression-free survival ratio for precision oncology
40. Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis
41. Detectability and structural stability of a liquid fiducial marker in fresh ex vivo pancreas tumour resection specimens on CT and 3T MRI
42. PD-L1 mRNA Detection in Immunohistochemically Negative Patients: A Complementary Method for a Better Treatment Selection?
43. Nicht kleinzelliges Lungenkarzinom – Vorreiter der personalisierten Onkologie
44. Typing of colon and lung adenocarcinoma by high throughput imaging mass spectrometry
45. 3rd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of pancreatic cancer
46. Response to Cabozantinib Following Acquired Entrectinib Resistance in a Patient With ETV6-NTRK3 Fusion-Positive Carcinoma Harboring the NTRK3G623R Solvent-Front Mutation
47. Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer
48. RAB27B expression in pancreatic cancer is predictive of poor survival but good response to chemotherapy
49. Supplementary Figure S13 from TIGIT Expression Delineates T-cell Populations with Distinct Functional and Prognostic Impact in Pancreatic Cancer
50. Supplementary Table S2 from TIGIT Expression Delineates T-cell Populations with Distinct Functional and Prognostic Impact in Pancreatic Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.